Interobserver Variability in Diagnosing STIC With Frequent Underdiagnosis of Early High-grade Serous Carcinoma: Insights From a Multicenter Review From the CANSTIC Study.

IF 2.1 4区 医学 Q3 OBSTETRICS & GYNECOLOGY
Sarah E J Khan, Martin Köbel, Elisabeth Spénard, Lien Hoang, Katherine Grondin, Marcus Q Bernardini, Marjan Rouzbahman
{"title":"Interobserver Variability in Diagnosing STIC With Frequent Underdiagnosis of Early High-grade Serous Carcinoma: Insights From a Multicenter Review From the CANSTIC Study.","authors":"Sarah E J Khan, Martin Köbel, Elisabeth Spénard, Lien Hoang, Katherine Grondin, Marcus Q Bernardini, Marjan Rouzbahman","doi":"10.1097/PGP.0000000000001218","DOIUrl":null,"url":null,"abstract":"<p><p>It has become widely accepted that most cases of tubo-ovarian high-grade serous carcinoma (HGSC) arise from precursor lesions in the fallopian tube called serous tubal intraepithelial carcinoma (STIC). This study evaluated the interobserver reproducibility of STIC diagnosis and its diagnostic boundaries from a multicentre Canadian cohort study. The multicentre CANSTIC study included patients with isolated STIC diagnosed between 1998 and 2020 across 15 Canadian centres. A blinded panel of 4 subspecialized gynecologic pathologists independently reviewed scanned slides (hematoxylin and eosin, p53, and Ki67) from 57 cases and met for a consensus meeting. Diagnoses were grouped as HGSC, STIC, and serous tubal intraepithelial lesion/other. The initial interobserver agreement for the diagnostic categories was moderate (Fleiss's kappa =0.495, 95% CI: 0.269-0.675; Cohen's kappa =0.492, 95% CI: 0.226-0.758, percent agreement 83.3%). A concordant diagnosis among all 4 reviewers was initially reached in 68% (39/57; 95% CI: 55.5%-79.0%), which increased to 91% (52/57; 95% CI: 81.1%-96.2%) after the consensus meeting. Consensus or majority (3 of 4 reviewers) was considered the final diagnosis; this resulted in STIC in 79% (45/57; 95% CI: 66.7-87.5), in agreement with the original diagnosis. Nine percent of cases were downgraded to serous tubal intraepithelial lesion/other (5/57; 95% CI: 1.8%-14.4%), while 12% were upgraded to HGSC (7/57; 95% CI: 6.1%-23.2%). Six patients developed HGSC clinically (11%; 95% CI: 4.9%-21.1%), of whom 3 had a review diagnosis of HGSC and 3 of STIC. This study shows suboptimal interobserver reproducibility for a diagnosis of STIC, despite consideration of ancillary p53/Ki67 testing. This study offers guidance to increase interobserver reproducibility in this challenging area, particularly in avoiding an underdiagnosis of HGSC.</p>","PeriodicalId":14001,"journal":{"name":"International Journal of Gynecological Pathology","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Gynecological Pathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/PGP.0000000000001218","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

It has become widely accepted that most cases of tubo-ovarian high-grade serous carcinoma (HGSC) arise from precursor lesions in the fallopian tube called serous tubal intraepithelial carcinoma (STIC). This study evaluated the interobserver reproducibility of STIC diagnosis and its diagnostic boundaries from a multicentre Canadian cohort study. The multicentre CANSTIC study included patients with isolated STIC diagnosed between 1998 and 2020 across 15 Canadian centres. A blinded panel of 4 subspecialized gynecologic pathologists independently reviewed scanned slides (hematoxylin and eosin, p53, and Ki67) from 57 cases and met for a consensus meeting. Diagnoses were grouped as HGSC, STIC, and serous tubal intraepithelial lesion/other. The initial interobserver agreement for the diagnostic categories was moderate (Fleiss's kappa =0.495, 95% CI: 0.269-0.675; Cohen's kappa =0.492, 95% CI: 0.226-0.758, percent agreement 83.3%). A concordant diagnosis among all 4 reviewers was initially reached in 68% (39/57; 95% CI: 55.5%-79.0%), which increased to 91% (52/57; 95% CI: 81.1%-96.2%) after the consensus meeting. Consensus or majority (3 of 4 reviewers) was considered the final diagnosis; this resulted in STIC in 79% (45/57; 95% CI: 66.7-87.5), in agreement with the original diagnosis. Nine percent of cases were downgraded to serous tubal intraepithelial lesion/other (5/57; 95% CI: 1.8%-14.4%), while 12% were upgraded to HGSC (7/57; 95% CI: 6.1%-23.2%). Six patients developed HGSC clinically (11%; 95% CI: 4.9%-21.1%), of whom 3 had a review diagnosis of HGSC and 3 of STIC. This study shows suboptimal interobserver reproducibility for a diagnosis of STIC, despite consideration of ancillary p53/Ki67 testing. This study offers guidance to increase interobserver reproducibility in this challenging area, particularly in avoiding an underdiagnosis of HGSC.

诊断STIC伴早期高级别浆液性癌常漏诊的观察者间差异:来自CANSTIC研究多中心综述的见解。
人们普遍认为,大多数输卵管卵巢高级别浆液性癌(HGSC)起源于输卵管的前体病变,称为浆液性输卵管上皮内癌(STIC)。本研究评估了来自加拿大多中心队列研究的STIC诊断的观察者间可重复性及其诊断界限。多中心CANSTIC研究纳入了1998年至2020年间在加拿大15个中心诊断的孤立性STIC患者。由4名亚专科妇科病理学家组成的盲法小组独立审查了57例患者的扫描切片(苏木精和伊红、p53和Ki67),并召开了共识会议。诊断分为HGSC、STIC和浆液性输卵管上皮内病变/其他。最初对诊断类别的观察者间一致性为中等(Fleiss的kappa =0.495, 95% CI: 0.269-0.675; Cohen的kappa =0.492, 95% CI: 0.226-0.758,一致性为83.3%)。4位审稿人初步诊断一致的比例为68% (39/57;95% CI: 55.5% ~ 79.0%),达到共识后增加到91% (52/57;95% CI: 81.1% ~ 96.2%)。共识或多数(4位审稿人中的3位)被认为是最终诊断;这导致了79%的STIC (45/57; 95% CI: 66.7-87.5),与最初的诊断一致。9%的病例降级为浆液性输卵管上皮内病变/其他(5/57;95% CI: 1.8%-14.4%),而12%的病例升级为HGSC (7/57; 95% CI: 6.1%-23.2%)。6例患者临床发展为HGSC (11%; 95% CI: 4.9%-21.1%),其中3例复查诊断为HGSC, 3例为STIC。尽管考虑到辅助的p53/Ki67检测,该研究显示诊断STIC的观察者间可重复性不理想。该研究为在这一具有挑战性的领域增加观察者之间的可重复性提供了指导,特别是在避免HGSC的诊断不足方面。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.90
自引率
12.50%
发文量
154
审稿时长
6-12 weeks
期刊介绍: International Journal of Gynecological Pathology is the official journal of the International Society of Gynecological Pathologists (ISGyP), and provides complete and timely coverage of advances in the understanding and management of gynecological disease. Emphasis is placed on investigations in the field of anatomic pathology. Articles devoted to experimental or animal pathology clearly relevant to an understanding of human disease are published, as are pathological and clinicopathological studies and individual case reports that offer new insights.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书